로딩 중…
지수 로딩 중…
Upstream Bio, Inc.
UPB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.25+1.63%
2026-06-18
Price Chart
Upstream Bio, Inc.-41.26%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $340M |
| Revenue | $3M |
| Net Income | $-157M |
| Total Assets | $318M |
| Net Assets | $304M |
| Value | |
| P/B | 1.12x |
| P/S | 102.39x |
| FCF Yield | -41.16% |
| Profitability | |
| ROE | -51.57% |
| ROA | -49.29% |
| Op. Margin | -5176.49% |
| Revenue Growth | 82.69% |
| Financial Health | |
| Debt Ratio | 4.62% |
| Total Debt | $1M |
| FCF | $-140M |
| Cash | $97M |
| Current Ratio | 23.14x |
| Performance | |
| 1Y Return | -41.26% |
| 1M Return | -22.17% |
| From 52W High | -81.44% |
| 1Y MDD | -81.84% |
| Trading | |
| Volume | 789,119 shares |
| Trading Value | $5M |
| Per Share | |
| EPS | $-1.87 |
| BPS | $7.02 |